“Chronic wounds such as diabetic foot ulcers have the pathophysiology ... other types of wounds such as burns, bedsores, venous leg ulcers and even surgical wounds.” The company plans to ...

Celularity (CELU) welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 2026, the effective date ...

Action delays to January 1, 2026, the effective date of a Biden-era Medicare LCD for skin substitute products used to treat diabetic foot ulcers and venous leg ulcers ...

Medical products group Convatec has said the sales outlook for InnovaMatrix has improved after an announcement by the US ...

As the prevalence of chronic wounds continues to rise, so does the demand for specialized wound care. Conditions such as ...

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for ...

As part of the transition to the new administration, CMS is reviewing its coverage policies for skin substitute products.

Medical products group Convatec shot to the top of the FTSE 100 as it said the sales outlook for InnovaMatrix has improved ...

The advanced wound care market was valued at $9,255.70 million in 2019, and is estimated to reach at $15,305.94 million by 2027, registering a CAGR of 11.6% from 2020 to 2027. Significant increase in ...

With the proposed LCDs not finalized, current MAC-specific coverage policies will remain in place through 2025. This includes broad coverage under the Novitas and FCSO LCDs for products with ...

BSEM READ THE FULL BSEM RESEARCH REPORT BioStem Technologies, Inc. (OTC:BSEM) is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, ...

These are the best compression socks you can shop right now, whether you're a frequent traveler or dealing with excessive ...